Laboratorio Clínico Segurilab, Quito, Ecuador.
Carrera de Ingeniería en Biotecnología, Universidad de las Américas, Quito, Ecuador.
Front Cell Infect Microbiol. 2023 Mar 9;13:1074953. doi: 10.3389/fcimb.2023.1074953. eCollection 2023.
The SARS-CoV-2 gold standard detection method is an RT-qPCR with a previous step of viral RNA extraction from the patient sample either by using commercial automatized or manual extraction kits. This RNA extraction step is expensive and time demanding.
The aim of our study was to evaluate the clinical performance of a simple SARS-CoV-2 detection protocol based on a fast and intense sample homogenization followed by direct RT-qPCR.
388 nasopharyngeal swabs were analyzed in this study. 222 of them tested positive for SARS-CoV-2 by the gold standard RNA extraction and RT-qPCR method, while 166 tested negative. 197 of those 222 positive samples were also positive for the homogenization protocol, yielding a sensitivity of 88.74% (95% IC; 83.83 - 92.58). 166 of those negative samples were also negative for the homogenization protocol, so the specificity obtained was 97% (95% IC; 93.11 - 99.01). For Ct values below 30, meaning a viral load of 10 copies/uL, only 4 SARS-CoV-2 positive samples failed for the RNA extraction free method; for that limit of detection, the homogenizer-based method had a sensitivity of 97.92% (95% CI; 96.01 - 99.83).
Our results show that this fast and cheap homogenization method for the SARS-CoV-2 detection by RT-qPCR is a reliable alternative of high sensitivity for potentially infectious SARS-CoV-2 positive patients. This RNA extraction free protocol would help to reduce diagnosis time and cost, and to overcome the RNA extraction kits shortage experienced during COVID-19 pandemic.
SARS-CoV-2 的金标准检测方法是一种 RT-qPCR,之前需要从患者样本中提取病毒 RNA,这可以通过使用商业自动化或手动提取试剂盒来完成。该 RNA 提取步骤既昂贵又费时。
本研究旨在评估一种简单的 SARS-CoV-2 检测方案的临床性能,该方案基于快速且剧烈的样本均化,随后直接进行 RT-qPCR。
本研究分析了 388 份鼻咽拭子。其中 222 份通过金标准 RNA 提取和 RT-qPCR 方法检测出 SARS-CoV-2 阳性,而 166 份检测结果为阴性。在这 222 份阳性样本中,有 197 份也通过均化方案呈阳性,灵敏度为 88.74%(95%CI;83.83-92.58)。在这 166 份阴性样本中,有 166 份也通过均化方案呈阴性,因此获得的特异性为 97%(95%CI;93.11-99.01)。对于 Ct 值低于 30 的样本,这意味着病毒载量为 10 拷贝/μL,只有 4 份 SARS-CoV-2 阳性样本未通过无 RNA 提取方法检出;对于该检测限,基于均化器的方法的灵敏度为 97.92%(95%CI;96.01-99.83)。
我们的结果表明,这种快速且廉价的 SARS-CoV-2 检测 RT-qPCR 均化方法是一种高灵敏度的可靠替代方法,适用于可能具有传染性的 SARS-CoV-2 阳性患者。这种无 RNA 提取方案有助于缩短诊断时间和降低成本,并克服在 COVID-19 大流行期间 RNA 提取试剂盒短缺的问题。